Endocrinology News Archive
Severe obesity may decline in children enrolled in specialized diet programs.
The investigators studied the association between abdominal fat, inflammation, and fitness by measuring body weight, dimensions, and blood samples.
A positive correlation between increased BMI and risk of prostate cancer recurrence was observed in patients undergoing radical prostatectomy.
Some of the comorbidities include increased lipid levels, hypertension, and diabetes.
There is no statistically significant difference in weight loss at 5 years after laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass in morbidly obese patients.
The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers.
More than 40 diet plans across 9 categories have been ranked to help those dieting achieve healthier lifestyles in U.S News & World Report.
Overweight/obese preschools have greater asthma symptoms than normal-weight children when untreated.
Findings do not support routine vitamin D and calcium supplementation in community-dwelling older adults for lowering the incidence of osteoporosis-related fractures.
The new FDA approved short-acting insulin drug can be used to treat T1 and T2 diabetes.
Body mass index BMI at a cut-point of 30 kg/m2 may not be an appropriate indicator of obesity in postmenopausal women.
Cocoa, dark chocolate, and raw almonds may help improve lipid profiles in overweight individuals.
Adult obesity by age of 35 is likely in about 57% of today's children.
The USPSTF has updated its recommendations on the use of menopausal hormone therapy for the primary prevention of chronic conditions.
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Weight-loss diets low in fat and saturated fat consumption, with or without added exercise, may reduce the risk for all-cause mortality in obese adults.
The USPSTF has updated its recommendations on osteoporosis screening and testing in women and men.
Incidence rates of overweight- and obesity-related cancers have increased in the United States.
Early menopause risk is highest in weight-cycling and severely underweight women.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
The meta-analysis showed that short-term probiotic supplementation reduced body weight, BMI, and fat percentage, but the effect sizes were small.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
With a little creativity, children with diabetes can enjoy the festivities of Halloween.
Among women who are attempting to conceive naturally, diminished ovarian reserve is not associated with infertility.
Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.
CBGT did not prevent overweight and obese patients with type 2 diabetes from regaining weight lost during weight loss programs.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
The AAP Section for Endocrinology compiled the list of tests for height and puberty, which should prompt careful discussion between parents and physicians.
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose.
After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.
The 12-year results show that Roux-en-Y gastric bypass offered long-term durability of weight loss and was associated with fewer obesity-related coexisting conditions compared with those who did not have the surgery.
The researchers found no long-term increase in either all-cause or cause-specific mortality among women who received hormone therapy for up to 5.6 years or 7.2 years, depending on the type of therapy.
Compared with normal-weight individuals, metabolically healthy obese individuals have an increased risk of coronary heart disease, cerebrovascular disease, and heart failure
The statement includes advances in care since the ADA's last position statement was published in 2003.
The increase in the demand for liver transplantation for nonalcoholic steatohepatitis is expected to continue with the current population obesity trends.
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
The gene-editing tool called CRISPR-Cas9 could have the potential to treat and prevent other genetic diseases.
Consumption of alcohol 3 to 4 days weekly is associated with a significantly lower risk for diabetes in men and women.
The USPSTF updated their 2012 recommendations on behavior lifestyle counseling for preventing cardiovascular disease.
Researchers found an association between poor metabolic health and depression, regardless of weight status.
Lifestyle interventions reduce gestational weight gain across various subgroups of women and lower the odds of cesarean section without affecting offspring outcomes.
Women who experienced early menopause were 2.4 times more likely to develop diabetes.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
Researchers found a paradoxical increase in thromboembolism risk in low-weight patients with atrial fibrillation and VTE who were treated with direct oral anticoagulants.
Thyroid disease may be a risk factor for manic relapse in patients with bipolar disorder.
The USPSTF has released updated recommendations on obesity screening in children and adolescents to focus on intensive behavioral interventions.
A point-of-care resource tool may help clinicians better manage childhood overweight- and obesity-related comorbidities.
Using collaboration and technology, NPs can help patients prevent weight gain and obesity-related diseases.
HIV-infected patients on ART had approximately 4 and 1.5 greater odds of developing diabetes mellitus and metabolic syndrome, respectively.
Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.
Gestational weight gain greater than or less than guideline recommendations is associated with an increased risk of adverse outcomes.
Patients who lost weight over a 48-month period had a lower rate of cartilage degeneration than patients who maintained stable weight.
Researchers used FRAX scores to examine the association of mental disorders and related medication use with osteoporotic fracture risk in clinical practice.
Patients with high risk for bipolar disorder are more likely to exhibit decreased cognitive performance as a function of increasing overweight status.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
The USPSTF recommends against screening for thyroid cancer in asymptomatic adults.
The score can predict the effectiveness of weight-loss therapy for preventing diabetes in overweight or obese individuals.
Patients exhibiting moderate-to-severe depressive symptoms had worse adherence than nondepressed patients.
Researchers found no association between metabolic syndrome and incident knee osteoarthritis.
Women who took probiotics in their second trimester had lower rates of gestational diabetes.
Patients taking linagliptin had decreased HbA1c as well as reactive oxygen species generation and plasma lipid peroxide levels.
Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.
Diabetes incidence rates in the US and glucose intolerance worldwide increased per 1°C increase in temperature.
A high BMI is associated with an increased risk for severe liver disease, and the risk is higher in those who also have type 2 diabetes mellitus.
The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.
Excess weight could influence the risk of of gastrointestinal cancers by altering insulin levels and promoting inflammation.
Individuals who consume the least amount of gluten are more likely to develop type 2 diabetes.
Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.
The position statement by the ADA incorporates updates in treatment and screening for patients with diabetic retinopathy.
Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated.
Researchers observed a reduced risk of all-cause mortality and CVD with dapagliflozin and a lower risk of mortality with dipeptidyl-peptidase-4 inhibitors.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
Prediabetes does not always show clear symptoms; however, it can lead to type 2 diabetes, heart disease, or stroke.
Among all women, PPD risk increased with advanced age and gestational diabetes.
Fasting glucose is specific but not sensitive, and HbA1c is neither sensitive nor specific.
Researchers observed a high efficacy rate for both glyburide and metformin.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
The most frequent enterovirus types included coxsackievirus A4, coxsackievirus A2, and coxsackievirus A16.
The study suggests that neither fish oil nor aspirin can be recommended for the prevention of AVF failure.
The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.
The FDA has approved a continuous glucose monitoring system to replace fingerstick blood sugar testing in patients with diabetes.
The procedure could be used as alternative to bariatric surgery for selected patients with obesity.
Higher ambulatory volume was linked to lower quality of care and quality increased with higher diabetes-specific volume.
The position statement provides recommendations for psychosocial assessment and care of individuals with diabetes.
Intrarosa provides an additional treatment option for women with dyspareunia caused by vulvar and vaginal atrophy.
Risk was dependent on dose, background medications, and type of GLP-1 receptor agonist.
The continuous glucose monitoring system detected 81% of hypoglycemic events within 30 minutes.
Combining FFR with imaging techniques may be required to guide the treatment strategy in patients with high-risk, fast-progressing atherosclerosis.
The USPSTF recommends that children and adolescents older than age 6 years should be screened for obesity.
The ADA releases its first independent recommendations on physical activity and exercise for all patients with diabetes.
Hepatic and peripheral insulin sensitivity in patients with type 2 diabetes were not affected by resveratrol treatment.
Women may have a higher risk of type 2 diabetes with low levels of sex hormone-binding globulin and high levels of total estradiol.
Women who experience more nighttime hot flashes are more likely to experience worsening mood during menopause.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Individuals with prediabetes may reduce their risk of diabetes with stepwise diabetes prevention.
Cognitive behavioral therapy, lisdexamfetamine, second-generation antidepressants, and topiramate reduced binge eating.
The American Heart Association found that during menopausal transition, women have a rapid increase in metabolic syndrome severity.